Northwest Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-839
Closed -$239K 169
2024
Q1
$239K Sell
839
-1
-0.1% -$293 0.07% 146
2023
Q4
$242K Buy
+840
New +$229K 0.07% 136
2019
Q2
Sell
-11
Closed -$2K 134
2019
Q1
$2K Hold
11
﹤0.01% 470
2018
Q4
$2K Hold
11
﹤0.01% 451
2018
Q3
$2K Hold
11
﹤0.01% 476
2018
Q2
$2K Hold
11
﹤0.01% 462
2018
Q1
$2K Buy
+11
New +$2.02K ﹤0.01% 475

Other funds holding AMGN

Northwest Wealth Management's AMGN Position: Q2 2024 in Review

Northwest Wealth Management sold out of Amgen (AMGN) in Q2 2024, closing a stake of 839 shares — an estimated $239K sold.

Northwest Wealth Management first reported a position in AMGN in Q1 2018 and held it in 7 quarters. The position peaked at $242K in Q4 2023. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • Northwest Wealth Management reported no remaining Amgen position as of Q2 2024 after selling out during the quarter.
  • Northwest Wealth Management sold 839 Amgen shares in Q2 2024, an estimated $239K.
  • Northwest Wealth Management first reported a position in Amgen in Q1 2018 and held it in 7 quarters.
  • Northwest Wealth Management's Amgen position peaked at $242K in Q4 2023.
  • 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on Northwest Wealth Management's 13F filing for Q2 2024, filed 5 Aug 2024.